Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200019487> ?p ?o ?g. }
- W4200019487 endingPage "110256" @default.
- W4200019487 startingPage "110256" @default.
- W4200019487 abstract "Inoculation against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is ongoing worldwide. However, the emergence of SARS-CoV-2 variants could cause immune evasion. We developed a bivalent nanoparticle vaccine that displays the receptor binding domains (RBDs) of the D614G and B.1.351 strains. With a prime-boost or a single-dose strategy, this vaccine elicits a robust neutralizing antibody and full protection against infection with the authentic D614G or B.1.351 strain in human angiotensin-converting enzyme 2 transgene mice. Interestingly, 8 months after inoculation with the D614G-specific vaccine, a new boost with this bivalent vaccine potently elicits cross-neutralizing antibodies for SARS-CoV-2 variants in rhesus macaques. We suggest that the D614G/B.1.351 bivalent vaccine could be used as an initial single dose or a sequential enforcement dose to prevent infection with SARS-CoV-2 and its variants." @default.
- W4200019487 created "2021-12-31" @default.
- W4200019487 creator A5003596217 @default.
- W4200019487 creator A5003759585 @default.
- W4200019487 creator A5005359731 @default.
- W4200019487 creator A5005496967 @default.
- W4200019487 creator A5013675782 @default.
- W4200019487 creator A5014307249 @default.
- W4200019487 creator A5017268360 @default.
- W4200019487 creator A5017424197 @default.
- W4200019487 creator A5019927126 @default.
- W4200019487 creator A5020559480 @default.
- W4200019487 creator A5024025818 @default.
- W4200019487 creator A5026606987 @default.
- W4200019487 creator A5026915472 @default.
- W4200019487 creator A5036822385 @default.
- W4200019487 creator A5042275051 @default.
- W4200019487 creator A5046518304 @default.
- W4200019487 creator A5047495310 @default.
- W4200019487 creator A5049711141 @default.
- W4200019487 creator A5052046758 @default.
- W4200019487 creator A5056463823 @default.
- W4200019487 creator A5062995314 @default.
- W4200019487 creator A5070245791 @default.
- W4200019487 creator A5075284563 @default.
- W4200019487 creator A5089169152 @default.
- W4200019487 creator A5091685833 @default.
- W4200019487 date "2022-01-01" @default.
- W4200019487 modified "2023-09-24" @default.
- W4200019487 title "A bivalent nanoparticle vaccine exhibits potent cross-protection against the variants of SARS-CoV-2" @default.
- W4200019487 cites W3001465255 @default.
- W4200019487 cites W3004280078 @default.
- W4200019487 cites W3008394341 @default.
- W4200019487 cites W3009335299 @default.
- W4200019487 cites W3010107438 @default.
- W4200019487 cites W3081892744 @default.
- W4200019487 cites W3086701718 @default.
- W4200019487 cites W3094860119 @default.
- W4200019487 cites W3108693782 @default.
- W4200019487 cites W3111426898 @default.
- W4200019487 cites W3120907105 @default.
- W4200019487 cites W3121365103 @default.
- W4200019487 cites W3122290535 @default.
- W4200019487 cites W3122875512 @default.
- W4200019487 cites W3127156551 @default.
- W4200019487 cites W3127231584 @default.
- W4200019487 cites W3127852352 @default.
- W4200019487 cites W3131287340 @default.
- W4200019487 cites W3131995220 @default.
- W4200019487 cites W3133745198 @default.
- W4200019487 cites W3133980772 @default.
- W4200019487 cites W3137469790 @default.
- W4200019487 cites W3138734145 @default.
- W4200019487 cites W3145164461 @default.
- W4200019487 cites W3149102402 @default.
- W4200019487 cites W3152591531 @default.
- W4200019487 cites W3154967470 @default.
- W4200019487 cites W3155004337 @default.
- W4200019487 cites W3157162195 @default.
- W4200019487 cites W3157709232 @default.
- W4200019487 cites W3159800361 @default.
- W4200019487 cites W3161032756 @default.
- W4200019487 cites W3161107225 @default.
- W4200019487 cites W3186290248 @default.
- W4200019487 doi "https://doi.org/10.1016/j.celrep.2021.110256" @default.
- W4200019487 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34990583" @default.
- W4200019487 hasPublicationYear "2022" @default.
- W4200019487 type Work @default.
- W4200019487 citedByCount "14" @default.
- W4200019487 countsByYear W42000194872022 @default.
- W4200019487 countsByYear W42000194872023 @default.
- W4200019487 crossrefType "journal-article" @default.
- W4200019487 hasAuthorship W4200019487A5003596217 @default.
- W4200019487 hasAuthorship W4200019487A5003759585 @default.
- W4200019487 hasAuthorship W4200019487A5005359731 @default.
- W4200019487 hasAuthorship W4200019487A5005496967 @default.
- W4200019487 hasAuthorship W4200019487A5013675782 @default.
- W4200019487 hasAuthorship W4200019487A5014307249 @default.
- W4200019487 hasAuthorship W4200019487A5017268360 @default.
- W4200019487 hasAuthorship W4200019487A5017424197 @default.
- W4200019487 hasAuthorship W4200019487A5019927126 @default.
- W4200019487 hasAuthorship W4200019487A5020559480 @default.
- W4200019487 hasAuthorship W4200019487A5024025818 @default.
- W4200019487 hasAuthorship W4200019487A5026606987 @default.
- W4200019487 hasAuthorship W4200019487A5026915472 @default.
- W4200019487 hasAuthorship W4200019487A5036822385 @default.
- W4200019487 hasAuthorship W4200019487A5042275051 @default.
- W4200019487 hasAuthorship W4200019487A5046518304 @default.
- W4200019487 hasAuthorship W4200019487A5047495310 @default.
- W4200019487 hasAuthorship W4200019487A5049711141 @default.
- W4200019487 hasAuthorship W4200019487A5052046758 @default.
- W4200019487 hasAuthorship W4200019487A5056463823 @default.
- W4200019487 hasAuthorship W4200019487A5062995314 @default.
- W4200019487 hasAuthorship W4200019487A5070245791 @default.
- W4200019487 hasAuthorship W4200019487A5075284563 @default.
- W4200019487 hasAuthorship W4200019487A5089169152 @default.
- W4200019487 hasAuthorship W4200019487A5091685833 @default.
- W4200019487 hasBestOaLocation W42000194872 @default.